FI3630967T3 - Proteaasi ja sitoutuva polypeptidi o-glykoproteiineja varten - Google Patents

Proteaasi ja sitoutuva polypeptidi o-glykoproteiineja varten Download PDF

Info

Publication number
FI3630967T3
FI3630967T3 FIEP18728576.2T FI18728576T FI3630967T3 FI 3630967 T3 FI3630967 T3 FI 3630967T3 FI 18728576 T FI18728576 T FI 18728576T FI 3630967 T3 FI3630967 T3 FI 3630967T3
Authority
FI
Finland
Prior art keywords
polypeptide
amino acid
glycoprotein
sequence
optionally
Prior art date
Application number
FIEP18728576.2T
Other languages
English (en)
Finnish (fi)
Inventor
Fredrik Leo
Rolf Lood-Alayón
Stephan Bjork
Malin Mejare
Fredrik Olsson
Original Assignee
Genovis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1708476.5A external-priority patent/GB201708476D0/en
Priority claimed from GBGB1708471.6A external-priority patent/GB201708471D0/en
Priority claimed from GBGB1806655.5A external-priority patent/GB201806655D0/en
Application filed by Genovis Ab filed Critical Genovis Ab
Application granted granted Critical
Publication of FI3630967T3 publication Critical patent/FI3630967T3/fi

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24057O-Sialoglycoprotein endopeptidase (3.4.24.57), i.e. glycoprotease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/924Hydrolases (3) acting on glycosyl compounds (3.2)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/952Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from bacteria

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
FIEP18728576.2T 2017-05-26 2018-05-25 Proteaasi ja sitoutuva polypeptidi o-glykoproteiineja varten FI3630967T3 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1708476.5A GB201708476D0 (en) 2017-05-26 2017-05-26 Tools for glycan analysis
GBGB1708471.6A GB201708471D0 (en) 2017-05-26 2017-05-26 Polypeptide
GBGB1806655.5A GB201806655D0 (en) 2018-04-24 2018-04-24 Polypeptide
PCT/EP2018/063832 WO2018215656A1 (en) 2017-05-26 2018-05-25 Protease and binding polypeptide for o-glycoproteins

Publications (1)

Publication Number Publication Date
FI3630967T3 true FI3630967T3 (fi) 2024-08-12

Family

ID=62492612

Family Applications (2)

Application Number Title Priority Date Filing Date
FIEP18728576.2T FI3630967T3 (fi) 2017-05-26 2018-05-25 Proteaasi ja sitoutuva polypeptidi o-glykoproteiineja varten
FIEP18728577.0T FI3630968T3 (fi) 2017-05-26 2018-05-25 Entsyymejä glykaanien analysointiin

Family Applications After (1)

Application Number Title Priority Date Filing Date
FIEP18728577.0T FI3630968T3 (fi) 2017-05-26 2018-05-25 Entsyymejä glykaanien analysointiin

Country Status (14)

Country Link
US (3) US11584922B2 (enExample)
EP (2) EP3630968B8 (enExample)
JP (3) JP2020521460A (enExample)
KR (2) KR102609790B1 (enExample)
CN (2) CN111183220B (enExample)
AU (2) AU2018272400B2 (enExample)
CA (2) CA3063815A1 (enExample)
DK (2) DK3630968T3 (enExample)
ES (2) ES2986557T3 (enExample)
FI (2) FI3630967T3 (enExample)
IL (2) IL270950B2 (enExample)
PL (2) PL3630968T3 (enExample)
PT (2) PT3630967T (enExample)
WO (2) WO2018215657A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3630968T3 (pl) 2017-05-26 2024-10-07 Genovis Ab Enzymy do analizy glikanów
AU2020301037A1 (en) * 2019-07-03 2022-02-03 Palleon Pharmaceuticals Inc. Recombinant human sialidases, sialidase fusion proteins, and methods of using the same
CN112795583A (zh) * 2020-11-16 2021-05-14 上海大学 重组唾液酸外切酶的制备方法、表达基因、重组表达载体及构建方法
WO2023114931A1 (en) * 2021-12-15 2023-06-22 Danisco Us Inc. Compositions and methods involving proteases specific for mannose-modified proteins
KR20250115409A (ko) * 2022-11-28 2025-07-30 암젠 인크 에타너셉트를 프로세싱하는 방법
US20260092921A1 (en) 2024-09-27 2026-04-02 Roche Diagnostics Gmbh Mutated neuroaminidase

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720165B2 (en) 2001-06-14 2004-04-13 Zyomix, Inc. Methods for making antibody fragments and compositions resulting therefrom
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
GB0624874D0 (en) 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
WO2009129086A2 (en) 2008-04-18 2009-10-22 New England Biolabs, Inc. Endoglycosidases that cleave o-linked glycans
EP2166085A1 (en) 2008-07-16 2010-03-24 Suomen Punainen Risti Veripalvelu Divalent modified cells
WO2010111691A2 (en) 2009-03-27 2010-09-30 Life Technologies Corp Conjugates of biomolecules to nanoparticles
GB201115841D0 (en) 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) 2013-09-20 2013-11-06 Genovis Ab Method
US10080787B2 (en) 2014-07-02 2018-09-25 New England Biolabs, Inc. Universal N-glycan binding reagent
WO2017052433A1 (en) 2015-09-24 2017-03-30 Saab Ab A modular fluid actuator system
AU2017214441B2 (en) 2016-02-04 2021-08-19 Genovis Ab New Streptococcal proteases
PL3630968T3 (pl) * 2017-05-26 2024-10-07 Genovis Ab Enzymy do analizy glikanów

Also Published As

Publication number Publication date
US20200087643A1 (en) 2020-03-19
CA3063828A1 (en) 2018-11-29
CA3063815A1 (en) 2018-11-29
IL270949B2 (en) 2025-06-01
PL3630968T3 (pl) 2024-10-07
PL3630967T3 (pl) 2024-11-18
EP3630967B8 (en) 2024-07-17
WO2018215656A9 (en) 2019-03-14
EP3630967A1 (en) 2020-04-08
CN111183221B (zh) 2024-04-09
IL270949A (en) 2020-01-30
DK3630967T3 (da) 2024-08-19
JP2023103233A (ja) 2023-07-26
CN111183220B (zh) 2024-03-22
US20200172889A1 (en) 2020-06-04
JP7195008B2 (ja) 2022-12-23
JP2020522242A (ja) 2020-07-30
WO2018215657A9 (en) 2019-03-14
AU2018272984A1 (en) 2019-12-05
ES2986910T3 (es) 2024-11-13
PT3630967T (pt) 2024-08-21
WO2018215656A1 (en) 2018-11-29
AU2018272400A1 (en) 2019-12-05
AU2018272984B2 (en) 2024-05-23
IL270949B1 (en) 2025-02-01
US12448614B2 (en) 2025-10-21
AU2018272400B2 (en) 2024-06-13
JP7557896B2 (ja) 2024-09-30
DK3630968T3 (da) 2024-07-29
ES2986557T3 (es) 2024-11-11
US11584922B2 (en) 2023-02-21
EP3630968B1 (en) 2024-05-29
IL270950A (en) 2020-01-30
EP3630968A1 (en) 2020-04-08
CN111183221A (zh) 2020-05-19
CN111183220A (zh) 2020-05-19
US20230212543A1 (en) 2023-07-06
WO2018215657A1 (en) 2018-11-29
EP3630967B1 (en) 2024-06-12
IL270950B2 (en) 2025-06-01
PT3630968T (pt) 2024-07-30
FI3630968T3 (fi) 2024-07-24
KR20200011955A (ko) 2020-02-04
KR102608876B1 (ko) 2023-11-30
EP3630968B8 (en) 2024-07-03
JP2020521460A (ja) 2020-07-27
IL270950B1 (en) 2025-02-01
KR102609790B1 (ko) 2023-12-04
KR20200010322A (ko) 2020-01-30
US12529044B2 (en) 2026-01-20

Similar Documents

Publication Publication Date Title
JP2020521460A5 (enExample)
Kollmann et al. Identification of novel lysosomal matrix proteins by proteome analysis
Schellenberger et al. The precursor to B-type natriuretic peptide is an O-linked glycoprotein
JP2019506866A5 (enExample)
FI3630968T3 (fi) Entsyymejä glykaanien analysointiin
US10507233B2 (en) Universal N-glycan binding reagent
KR20230091199A (ko) 탈당화 시약 및 방법
WO2021236716A3 (en) Methods, systems and kits for polypeptide processing and analysis
JP2020522242A5 (enExample)
Cruz et al. Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate
CA3083859A1 (en) A method and products for the diagnosis of a seafood allergy
JP6462820B2 (ja) プロテインタグ、タグ化タンパク質及びタンパク質精製方法
JP7513233B2 (ja) アレルゲン検出用マーカーおよびそれを用いたアレルゲン検出方法
JP6445861B2 (ja) オキシトシン検出のためのサンプルの前処理方法
Nakagawa et al. Efficient expression and purification of tag-free recombinant human procalcitonin (hPCT) with precise sequence in E. coli
WO2003070768A3 (en) Cd40 splice variants,method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof
CA3114617A1 (en) Peptide ligands for capture of host cell proteins
CN105277398A (zh) 一种特殊糖肽富集和鉴定的方法
US20160319323A1 (en) Method for determining site having n-linked sugar chain added thereto or proportion of said addition
Ogura et al. Proneurotensin/neuromedin N secreted from small cell lung carcinoma cell lines as a potential tumor marker
US20050153383A1 (en) Synthetic and recombinant substrates for the detecion of the von willebrand factor-cleaving protease
US20250044296A1 (en) Reagent for measuring b-glucan, method for producing same and use thereof
WO2011089453A4 (en) Mass spectrometry-based protein identification
Suzuki et al. Amino Acid Sequence Studies on Cyanogen Bromide Peptides of Chicken Caldesmon Which Bind to Calmodulin1
RU2007142850A (ru) Пептид ded и его применение для идентификации и/или очистки рекомбинантных белков, вектор pded